Chaobin He
Impact in
- Biotechnology top 2%
- Microbial Inactivation Methods
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 27
- Pancreatic and Hepatic Oncology Research 18
- Inflammatory Biomarkers in Disease Prognosis 5
-
- Microbial Inactivation Methods 18
- Co-authors
- Xiaojun Lin (33 shared papers)Shengping Li (31 shared papers)Zhiyuan Cai (14 shared papers)Xin Huang (20 shared papers)Shuxin Sun (15 shared papers)Yu Zhang (10 shared papers)Yize Mao (10 shared papers)Jun Wang (5 shared papers)
- Journals
- Frontiers in Oncology (13 papers)Journal of Inflammation Research (5 papers)BMC Cancer (5 papers)Journal of Cancer (5 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Chaobin He
59 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 76
- Biotechnology 226
- Oncology 391
- Hepatology 57
- Immunology 122
- Cancer Research 80
Countries citing papers authored by Chaobin He
This map shows the geographic impact of Chaobin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaobin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaobin He more than expected).
Fields of papers citing papers by Chaobin He
This network shows the impact of papers produced by Chaobin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaobin He. The network helps show where Chaobin He may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaobin He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 62 | |
| 2 | 2020 | 60 | |
| 3 | 2021 | 59 | |
| 4 | 2017 | 45 | |
| 5 | 2019 | 42 | |
| 6 | 2018 | 42 | |
| 7 | 2021 | 39 | |
| 8 | 2018 | 36 | |
| 9 | 2019 | 32 | |
| 10 | 2018 | 32 | |
| 11 | 2019 | 31 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 28 | |
| 14 | 2017 | 27 | |
| 15 | 2021 | 26 | |
| 16 | 2021 | 26 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 22 | |
| 19 | 2020 | 22 | |
| 20 | 2019 | 21 |
About Chaobin He
Chaobin He is a scholar working on Oncology, Biotechnology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 63 papers that have together received 1.0k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (18 papers), Pancreatic and Hepatic Oncology Research (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Cancer Genomics and Diagnostics (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Gallbladder and Bile Duct Disorders (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Biotechnology (226 citations), Oncology (391 citations), Hepatology (57 citations), Immunology (122 citations) and Cancer Research (80 citations). Chaobin He has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Xiaojun Lin, Shengping Li, Zhiyuan Cai, Xin Huang, Shuxin Sun, Yu Zhang, Yize Mao, Jun Wang, Yu Zhang and Xiang‐Ming Lao. Their work appears in journals such as Frontiers in Oncology, Journal of Inflammation Research, BMC Cancer, Journal of Cancer and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.